According to SEC filings for the period ending December 2025, Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is held by 270 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 31 Dec, 2025 | 10,263,815 | 131,087 | 1.29% | $236,067,745.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 6,631,554 | 206,291 | 3.21% | $152,525,742.00 |
| STATE STREET CORP | 31 Dec, 2025 | 4,303,046 | 610,559 | 16.54% | $98,970,058.00 |
| JPMORGAN CHASE & CO | 31 Dec, 2025 | 3,974,030 | -37,399 | -0.93% | $91,402,705.00 |
| SANDS CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 3,485,724 | -284,129 | -7.54% | $80,171,652.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 3,000,139 | -258,127 | -7.92% | $69,003,197.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 2,772,692 | 0 | 0.00% | $63,771,916.00 |
| FMR LLC | 31 Dec, 2025 | 2,666,249 | -4,617,047 | -63.39% | $61,323,732.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 2,461,910 | 516,781 | 26.57% | $56,623,930.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 2,326,125 | 1,995,172 | 602.86% | $53,500,875.00 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 2,019,000 | 0 | 0.00% | $46,437,000.00 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 31 Dec, 2025 | 1,965,084 | 895,986 | 83.81% | $45,196,925.00 |
| BNP Paribas Asset Management Holding S.A. | 31 Dec, 2025 | 1,899,661 | 354,382 | 22.93% | $43,692.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 1,838,208 | 257,701 | 16.30% | $42,287,465.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 1,826,295 | 916,112 | 100.65% | $42,004,816.00 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31 Dec, 2025 | 1,749,268 | -418,461 | -19.30% | $40,233,164.00 |
| Aberdeen Group plc | 31 Dec, 2025 | 1,469,951 | 496,295 | 50.97% | $33,808,873.00 |
| GW&K Investment Management, LLC | 31 Dec, 2025 | 1,375,407 | 225,238 | 19.58% | $31,634.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 1,360,497 | 614,315 | 82.33% | $31,291,431.00 |
| Rock Springs Capital Management LP | 31 Dec, 2025 | 1,267,241 | 20,900 | 1.68% | $29,146,543.00 |